Cargando…
A comprehensive multiplex PCR based exome-sequencing assay for rapid bloodspot confirmation of inborn errors of metabolism
BACKGROUND: Tandem mass spectrometry (MS MS) and simple fluorometric assays are currently used in newborn screening programs to detect inborn errors of metabolism (IEM). The aim of the study was to evaluate the clinical utility of exome sequencing as a second tier screening method to assist clinical...
Autores principales: | Wang, Wenjie, Yang, Jianping, Xue, Jinjie, Mu, Wenjuan, Zhang, Xiaogang, Wu, Wang, Xu, Mengnan, Gong, Yuyan, Liu, Yiqian, Zhang, Yu, Xie, Xiaobing, Gu, Weiyue, Bai, Jigeng, Cram, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322297/ https://www.ncbi.nlm.nih.gov/pubmed/30612563 http://dx.doi.org/10.1186/s12881-018-0731-5 |
Ejemplares similares
-
The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism
por: Bessey, Alice, et al.
Publicado: (2020) -
Intronic variants in inborn errors of metabolism: Beyond the exome
por: Hertzog, Ashley, et al.
Publicado: (2022) -
Identification of Clinical Variants beyond the Exome in Inborn Errors of Metabolism
por: Soriano-Sexto, Alejandro, et al.
Publicado: (2022) -
Whole-exome sequencing for detecting inborn errors of immunity: overview and perspectives
por: Bosch, Barbara, et al.
Publicado: (2017) -
Genetic diagnosis of inborn errors of immunity using clinical exome sequencing
por: Kwon, Soon Sung, et al.
Publicado: (2023)